Liu C - Search Results

1

Delivery of Protein Kinase A by CRISPRMAX and Its Effects on Breast Cancer Stem-Like Properties.

Zhou JN, Rautio TC, Liu C, Xu XY, Wang DQ, Guo Y, Eriksson J, Zhang H. Zhou JN, et al. Among authors: liu c. Pharmaceutics. 2020 Dec 23;13(1):11. doi: 10.3390/pharmaceutics13010011. Pharmaceutics. 2020. PMID: 33374889 Free PMC article.

2

Mineralization of pH-Sensitive Doxorubicin Prodrug in ZIF-8 to Enable Targeted Delivery to Solid Tumors.

Yan J, Liu C, Wu Q, Zhou J, Xu X, Zhang L, Wang D, Yang F, Zhang H. Yan J, et al. Among authors: liu c. Anal Chem. 2020 Aug 18;92(16):11453-11461. doi: 10.1021/acs.analchem.0c02599. Epub 2020 Jul 27. Anal Chem. 2020. PMID: 32664723 Free PMC article.

3

Nanotechnology-based delivery of CRISPR/Cas9 for cancer treatment.

Xu X, Liu C, Wang Y, Koivisto O, Zhou J, Shu Y, Zhang H. Xu X, et al. Among authors: liu c. Adv Drug Deliv Rev. 2021 Sep;176:113891. doi: 10.1016/j.addr.2021.113891. Epub 2021 Jul 26. Adv Drug Deliv Rev. 2021. PMID: 34324887 Free article. Review.

4

Improving the knock-in efficiency of the MOF-encapsulated CRISPR/Cas9 system through controllable embedding structures.

Liu C, Xu X, Koivisto O, Zhou W, Jacquemet G, Rosenholm JM, Zhang H. Liu C, et al. Nanoscale. 2021 Oct 14;13(39):16525-16532. doi: 10.1039/d1nr02872c. Nanoscale. 2021. PMID: 34596650

5

Fabrication of a pH/Redox-Triggered Mesoporous Silica-Based Nanoparticle with Microfluidics for Anticancer Drugs Doxorubicin and Paclitaxel Codelivery.

Yan J, Xu X, Zhou J, Liu C, Zhang L, Wang D, Yang F, Zhang H. Yan J, et al. Among authors: liu c. ACS Appl Bio Mater. 2020 Feb 17;3(2):1216-1225. doi: 10.1021/acsabm.9b01111. Epub 2020 Jan 27. ACS Appl Bio Mater. 2020. PMID: 35019322

6

In Vivo Kidney Allograft Endothelial Specific Scavengers for On-Site Inflammation Reduction under Antibody-Mediated Rejection.

Liu C, Yan P, Xu X, Zhou W, Prakash DR, Wang S, Zhou J, Wang R, Huang H, Chen J, Zhang H, Shen J. Liu C, et al. Small. 2022 Sep;18(36):e2106746. doi: 10.1002/smll.202106746. Epub 2022 Mar 2. Small. 2022. PMID: 35235710

7

Self-assembly of DNA nanogels with endogenous microRNA toehold self-regulating switches for targeted gene regulation therapy.

Yan J, Zou H, Zhou W, Yuan X, Li Z, Ma X, Liu C, Wang Y, Rosenholm JM, Cui W, Qu X, Zhang H. Yan J, et al. Among authors: liu c. Biomater Sci. 2022 Jul 26;10(15):4119-4125. doi: 10.1039/d2bm00640e. Biomater Sci. 2022. PMID: 35789225

8

Helper T Cell (CD4⁺) Targeted Tacrolimus Delivery Mediates Precise Suppression of Allogeneic Humoral Immunity.

Shen J, Liu C, Yan P, Wang M, Guo L, Liu S, Chen J, Rosenholm JM, Huang H, Wang R, Zhang H. Shen J, et al. Among authors: liu c, liu s. Research (Wash D C). 2022 Jul 16;2022:9794235. doi: 10.34133/2022/9794235. eCollection 2022. Research (Wash D C). 2022. PMID: 35958106 Free PMC article.

9

Microfluidic-assisted biomineralization of CRISPR/Cas9 in near-infrared responsive metal-organic frameworks for programmable gene-editing.

Xu X, Liu C, Wang S, Mäkilä E, Wang J, Koivisto O, Zhou J, Rosenholm JM, Shu Y, Zhang H. Xu X, et al. Among authors: liu c. Nanoscale. 2022 Nov 3;14(42):15832-15844. doi: 10.1039/d2nr04095f. Nanoscale. 2022. PMID: 36255392 Free article.

10

Hybrid Nanoparticles for Haloperidol Encapsulation: Quid Est Optimum?

Filippov SK, Khusnutdinov RR, Inham W, Liu C, Nikitin DO, Semina II, Garvey CJ, Nasibullin SF, Khutoryanskiy VV, Zhang H, Moustafine RI. Filippov SK, et al. Among authors: liu c. Polymers (Basel). 2021 Nov 30;13(23):4189. doi: 10.3390/polym13234189. Polymers (Basel). 2021. PMID: 34883693 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

73,444 results

Search Page